Search

Navigator™

Navigator™ is a clinical decision support system that enables a systematic approach to hemodynamic management. Navigator™ is Applied Physiology’s flagship product and is due for release early next year pending regulatory approval.

Navigator™ connects to conventional monitors and uses a series of mathematical algorithms draw a map of the patient’s status in relation to the patient target zone (PTZ). The PTZ is drawn based on patient specific pressure and flow targets set by the clinician. A red dot represents the patient status, and the corresponding arrow indicates the target zone path - the direction that will bring the patient closer to all of the defined targets. This self-adaptive protocol enhances teamwork and standardizes care by unifying the goals of the clinicians.

This implementation of targeted therapy is expected to improve patient outcomes in critical care units.

Navigator™ is designed for use in critical care units where resuscitation, stabilization and optimization of hemodynamic and oxygen metabolism is required. It is recommended for use on a broad range of patients including those undergoing or suffering from:

  • Pre and post open heart surgery
  • Pre and post major surgery
  • Hypo/Hypervolemic shock
  • Septic shock
  • Cardiogenic shock
  • Drug overdose
  • Sedated patients
  • Renal failure
  • Major burns
  • Major trauma

Navigator™ will be available for sale in Europe and Australia in the second quarter 2010. It will be available for sale in the US pending regulatory approval from the FDA.

  

Navigator™ Brochure

Applied Physiology at the Bedside
A Satellite Symposium chaired by Dr Michael Pinsky.

“Any device that can instantaneously represent the state of the patient and help you control that patient while [you’re] doing all the other aspects of your job is so potentially beneficial it’s incredible. That’s what the Navigator can do.”
Dr Vincent Pellegrino Intensive care specialist, the Alfred Hospital, Melbourne Australia